Top

Grape-based compounds kill colon cancer stem cells in mice

June 22, 2017 by · Leave a Comment 

Compounds from grapes may kill colon cancer stem cells both in a petri dish and in mice, according to a team of researchers.

The compounds — resveratrol –which are found in grape skins and seeds, could also eventually lead to treatments to help prevent colon cancer, said Jairam K.P. Vanamala, associate professor of food sciences, Penn State. Colorectal cancer is the second leading cause of cancer-related deaths in the U.S., according to the American Cancer Society.

“The combination of resveratrol and grape seed extract is very effective at killing colon cancer cells,” said Vanamala, who is also a faculty member at the Penn State Hershey Cancer Institute. “And what we’re learning is the combination of these compounds is not toxic to healthy cells.”

Read more

Blocking differentiation is enough to give cells ‘stemness’

October 23, 2015 by · Leave a Comment 

Though immune therapy and regenerative medicine are promising areas of research for future medical therapies, they are limited today by the difficulty of creating stem cells, and scientists around the world are searching for ways to create somatic stem cells in the easiest way possible. Now, a collaboration between the RIKEN Center for Integrative Medical Science (IMS) and other institutions in Japan and Europe have found that in immune cells, simply blocking a transcription factor that leads to differentiation is sufficient to keep cells in a multipotent stem cell-like state where they can continue to proliferate and can later differentiate into various cell types.

Read more

Sleep deprivation affects stem cells, reducing transplant efficiency, study finds

October 14, 2015 by · Leave a Comment 

Drowsy mice make poor stem cell donors, according to a new study by researchers at the Stanford University School of Medicine.

Read more

Johns Hopkins biologist leads research shedding light on stem cells

October 8, 2015 by · Leave a Comment 

A Johns Hopkins University biologist has led a research team reporting progress in understanding the mysterious shape-shifting ways of stem cells, which have vast potential for medical research and disease treatment.

Read more

Restoring vision with stem cells

October 8, 2015 by · Leave a Comment 

Age-related macular degeneration (AMRD) could be treated by transplanting photoreceptors produced by the directed differentiation of stem cells, thanks to findings published today by Professor Gilbert Bernier of the University of Montreal and its affiliated Maisonneuve-Rosemont Hospital. ARMD is a common eye problem caused by the loss of cones. Bernier’s team has developed a highly effective in vitro technique for producing light sensitive retina cells from human embryonic stem cells. “Our method has the capacity to differentiate 80% of the stem cells into pure cones,” Professor Gilbert explained. “Within 45 days, the cones that we allowed to grow towards confluence spontaneously formed organised retinal tissue that was 150 microns thick. This has never been achieved before.”

Read more

A snapshot of stem cell expression

October 2, 2015 by · Leave a Comment 

Researchers on the Wellcome Genome Campus reveal new genes involved in stem cell pluripotency, new subpopulations of cells and new methods to find meaning in the data. Published in Cell Stem Cell, the findings have implications for the study of early development.

Read more

Sticky gel helps stem cells heal rat hearts

September 28, 2015 by · Leave a Comment 

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, according to results of a new study.

Read more

Filling a void in stem cell therapy

September 15, 2015 by · Leave a Comment 

Stem cell therapies are often limited by low survival of transplanted stem cells and the lack of precise control over their differentiation into the terminal cell types needed to repair or replace injured tissues. Now, a team led by Wyss Institute Core Faculty member David Mooney, Ph.D., has developed a new strategy – embedding stem cells into porous, transplantable hydrogels – that has experimentally improved bone repair by boosting the survival rate of transplanted stem cells and influencing their cell differentiation.

Read more

Discovery offers hope for treating leukemia relapse post-transplant

September 11, 2015 by · Leave a Comment 

Targeting exhausted immune cells may change the prognosis for patients with acute myeloid leukemia (AML) relapse after a stem cell transplant, according to Penn State College of Medicine researchers.

Read more

Sustained remission of multiple myeloma achieved after personalized cellular therapy

September 10, 2015 by · Leave a Comment 

A multiple myeloma patient whose cancer had stopped responding after nine different treatment regimens experienced a complete remission after receiving an investigational personalized cellular therapy known as CTL019 developed by a team at the University of Pennsylvania. The investigational treatment was combined with chemotherapy and an autologous stem cell transplant – a new strategy designed to target and kill the cells that give rise to myeloma cells.

Read more

Next Page »

Bottom